Ascentage Pharma Group International (ASPHF)
USD 2.69
(0.0%)
USD 2.69
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -838.93 Million CNY | 0.85% |
| 2022 | -846.12 Million CNY | 3.44% |
| 2021 | -876.22 Million CNY | -31.67% |
| 2020 | -665.44 Million CNY | 55.14% |
| 2019 | -1.48 Billion CNY | -333.02% |
| 2018 | -342.53 Million CNY | -248.53% |
| 2017 | -98.28 Million CNY | 16.42% |
| 2016 | -117.59 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q3 | -36.43 Million USD | -46.91% |
| 2023 Q4 | -37.48 Million USD | -2.86% |
| 2023 Q1 | -26.2 Million USD | 24.55% |
| 2023 FY | -838.93 Million CNY | 0.85% |
| 2023 Q2 | -24.8 Million USD | 5.35% |
| 2022 Q4 | -34.72 Million USD | -3.16% |
| 2022 Q2 | -62.2 Million USD | 0.0% |
| 2022 FY | -846.12 Million CNY | 3.44% |
| 2022 Q3 | -33.66 Million USD | 45.88% |
| 2021 Q2 | -58.97 Million USD | 0.0% |
| 2021 FY | -876.22 Million CNY | -31.67% |
| 2021 Q4 | -85.59 Million USD | 0.0% |
| 2020 FY | -665.44 Million CNY | 55.14% |
| 2020 Q2 | -44.21 Million USD | 0.0% |
| 2020 Q4 | -55.17 Million USD | 0.0% |
| 2019 Q2 | -36.94 Million USD | 0.0% |
| 2019 Q4 | -50.67 Million USD | 0.0% |
| 2019 FY | -1.48 Billion CNY | -333.02% |
| 2018 FY | -342.53 Million CNY | -248.53% |
| 2017 FY | -98.28 Million CNY | 16.42% |
| 2016 FY | -117.59 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -59738.615% |
| CSL Limited | 3.7 Billion USD | 122.662% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | -1068.657% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 17169.466% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -320438.273% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -4600.689% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 1124.939% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -54516.226% |
| Mesoblast Limited | -84.14 Million USD | -896.984% |
| Marizyme, Inc. | -34.08 Million USD | -2361.184% |
| Genus plc | 6.4 Million USD | 13208.313% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 8711.091% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -89974.084% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -9947.09% |
| ContraFect Corporation | -56.88 Million USD | -1374.682% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -18318.935% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| IMV Inc. | -38.67 Million USD | -2069.38% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -30397.314% |
| MultiCell Technologies, Inc. | -722.81 USD | -116065256.041% |
| Accustem Sciences Inc. | -3.74 Million USD | -22292.904% |
| RVL Pharmaceuticals plc | -58.99 Million USD | -1322.16% |
| EV Biologics, Inc. | -483.06 Thousand USD | -173569.632% |
| Q BioMed Inc. | -3.44 Million USD | -24247.809% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 23798.644% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -31828.638% |
| Biomind Labs Inc. | -1 Million USD | -82995.236% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -12519.286% |
| Skye Bioscience, Inc. | -13.67 Million USD | -6036.222% |
| SQZ Biotechnologies Company | -75.82 Million USD | -1006.406% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -2800821.474% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -16530.683% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -29330.975% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -5186.364% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -215248.204% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | -17092.836% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -42132.11% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -43309.276% |
| GB Sciences, Inc. | -1.42 Million USD | -58958.549% |
| Alpha Cognition Inc. | -9.7 Million USD | -8543.792% |
| argenx SE | -425.04 Million USD | -97.373% |
| HST Global, Inc. | -140.9 Thousand USD | -595279.931% |
| Halberd Corporation | -75.05 Thousand USD | -1117730.779% |
| Enzolytics Inc. | -2.14 Million USD | -38941.884% |
| Resverlogix Corp. | -12.74 Million USD | -6480.375% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -26379.149% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | -1411.371% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | -1426.098% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -80257.471% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -28816.226% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -28636.02% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -44898.15% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -53018.647% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -24538.39% |
| AVAX Technologies, Inc. | 6.69 Million USD | 12634.694% |
| ONE Bio Corp. | 13.68 Million USD | 6231.85% |
| Zenith Capital Corp. | -8.94 Million USD | -9280.879% |
| Genscript Biotech Corporation | -415.79 Million USD | -101.768% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -4815536.301% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -34067.971% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -489045.968% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -41747.067% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -74477.965% |
| Agentix Corp. | -1.37 Million USD | -61057.524% |
| Adynxx, Inc. | - USD | Infinity% |
| Kadimastem Ltd | -3.04 Million USD | -27494.178% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -85152.725% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -66693.949% |
| BioStem Technologies, Inc. | -7.77 Million USD | -10684.617% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -462159.691% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -62721.067% |
| LadRx Corporation | -3.82 Million USD | -21840.744% |
| Cell Source, Inc. | -4.32 Million USD | -19295.72% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -201819.231% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -122024.172% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -122024.172% |
| NovAccess Global Inc. | -2.46 Million USD | -33909.47% |
| Affymax, Inc. | -15.04 Million USD | -5475.781% |
| Itoco Inc. | -919.14 Thousand USD | -91173.582% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -19693.536% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -74871.582% |
| CytoDyn Inc. | -18.05 Million USD | -4545.764% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -3332963.17% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -381097.575% |
| Qrons Inc. | -643.67 Thousand USD | -130234.314% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -148456.372% |
| SYBLEU INC | -149.18 Thousand USD | -562262.247% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -37522.31% |
| Rebus Holdings, Inc. | -664 Thousand USD | -126245.181% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -46088.557% |
| Mobile Lads Corp. | -554.55 Thousand USD | -151181.58% |
| International Stem Cell Corporation | -663 Thousand USD | -126435.747% |
| Bioxytran, Inc. | -3.82 Million USD | -21860.726% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -1593615.805% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -4124442.773% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -2213.274% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -51749.938% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -113910.886% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -26866.635% |
| Neutra Corp. | -229.48 Thousand USD | -365470.013% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -4683.237% |
| PureTech Health plc | -146.19 Million USD | -473.829% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -3803.622% |
| IXICO plc | -1.43 Million USD | -58280.793% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -8739.237% |
| Gelesis Holdings, Inc. | -121.8 Million USD | -588.744% |
| CSL Limited | 3.81 Billion USD | 122.008% |
| Cellectis S.A. | -108.85 Million USD | -670.671% |